(19)
(11) EP 1 689 714 A2

(12)

(88) Date of publication A3:
15.09.2005

(43) Date of publication:
16.08.2006 Bulletin 2006/33

(21) Application number: 04801265.2

(22) Date of filing: 06.12.2004
(51) International Patent Classification (IPC): 
C07D 213/20(2006.01)
A61K 31/4425(2006.01)
A61P 37/00(2006.01)
A61P 9/06(2006.01)
A61K 45/06(2006.01)
C07D 495/04(2006.01)
A61K 31/4439(2006.01)
A61P 37/06(2006.01)
A61P 3/10(2006.01)
(86) International application number:
PCT/GB2004/005109
(87) International publication number:
WO 2005/054198 (16.06.2005 Gazette 2005/24)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 05.12.2003 GB 0328314

(71) Applicant: UNIVERSITY OF BATH
Claverton Down, Bath, BA2 7AY (GB)

(72) Inventors:
  • POTTER, B.V.l University of Bath
    Bath BA2 7AY (GB)
  • DOWDEN, James, University of Bath
    Bath BA2 7AY (GB)
  • GALIONE, Antony, Oxford University
    Oxford OX1 3QT (GB)

(74) Representative: Harding, Charles Thomas et al
D Young & Co 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) THERAPEUTIC USE OF PYRIDINIUM COMPOUNDS TO MODULATE NAADP ACTIVITY